Back to Search
Start Over
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600–Mutant Pediatric High-Grade Glioma.
- Source :
- Journal of Clinical Oncology; 11/20/2023, Vol. 41 Issue 2, p5174-5183, 16p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 41
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173622063
- Full Text :
- https://doi.org/10.1200/JCO.23.00558